| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | Plasmodium falciparum (isolate 3D7) Asparagine-rich antigen |
| | Pfa35-2 (a.a.61-460) |
| | Swiss-Prot #: | Q8I284 |
| | Entry name: | Q8I284_PLAF7 |
| | Protein | Asparagine-rich antigen Pfa35-2 |
| | Gene names: | PFA_0280w |
| | Organism: | Plasmodium falciparum (isolate 3D7) |
| | Codon-optimized cDNA Clone |
| | Cat#: | RPL-0460 |
| | Description: | Applications:1. Codon-optimized cDNA sequence designed for recombinant |
| | protein production in both E.coli and Mammalian cell. The cDNA has been |
| | cloned into E.coli expression vector with 6x Histidine tag. 2. May be used as |
| | RNAi assistance to restore the loss-of-function. |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Recombinant Protein |
| | Cat#: | PL-0460 |
| | Source: | Recombinant protein derived from E.coli. Or Yeast |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Purity: | > 90%, as determined by SDS-PAGE under reducing conditions |
| | Activity: | N/A |
| | Applications: | Western Blot, may be used for other applications determined by |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Sequence: | | MKKNPKSIEE ITDLPHVDNS DNCMKMNNIK NGDDGNNNYG KSDNTNETNL NDTLSYNKYG NNFLSYNGNY GSNKMYSNQN |
| | INNRYYNKIH FNEENYEYFG RGRNYKNCNN NGNYNNNNNN NYNYYNHYNN NSSSNNNNNN NSSGISNNYH DGDYVKYNKK |
| | GSTIHNRYNN IYTTSTTHNT YNNNNNNNNS SSSSHNFHIS NNNLSGNNYH YYNPYNYYNG CTTIDNELNE KDHKQISSKK |
| | MSNSVATARS EYTSESKEYQ ANDINKKKNE FNRNDTCKND VKTNDVKTND VKTNDVKTND GQTNDVKTND VKTNDMKTND |
| | MKTNDMKTND MKTNDIRPMN KDQNMKKNIR INKNYFPKGI TSPRNNGNTN DTYIRDDNVL NTYEESFTMK NKKKNYYRYQ |
| | NNYKNNTSNH FYNSLNMKLI NYGNFGYNNN NHYNNSYNNS SNNYYHNNNY HNNHRVNIHM NYRNKNNCMN NYYPYNNYID |
| | TKENDTMQKG TSSRNILYDN KNDDTNFNCF GKDKYANKKN EIDKNQNDSV VVYDENTNKE DHKDDNKNSS NDNIPNVNNS |
| | DNCNLTSDDR IKSSIQENNT CISPKNNSVV LNNTNMEENR SYSNNDNASK DIIMDNMCDK YKKEGKPSEN SVYVNTYNDK |
| | EKTNHDSDVA MEKDNSDIIY TEIEQNYNKK NNNNDKKKED NIANVKAHSN FYDTFDNNDK RDDENGMAEI KGEEENLDIK |
| | KISNKNSMNK NNVSYLENEQ YLKCKIGEVK NKNEQGNTAE DNNNNNNNYS NNNNNNSNYN SNYNYNYYYH NNINDYDDYY |
| | DINDNNNLFK DENFDNSTNN KSFKYNNRNN IKNDHSFKSH IQCNMNNSYN YSNGNTLHCE GSKELSYEKN HYSFSKNETF |
| | KKKGPNKNYT NGYNFNYSNR SGKNMKNHNY AYNNFNAGYQ RSNMSKDNKY NDNEGNNMYE NGENNNKGDT IKNNDIIYDK |
| | REDDKNIKHV KYDDDHNQNR DNDEDKDKDH NQDKDRNQDK DRNQDKDRNQ DKDHNQDKDR NQDKDRNQDK DHNQDKDHNQ |
| | DKDHNQDKDH NQDQNQDQNQ DSIIKNNHII SIEDDKKECE IYYHRDNNII NFDKTDNNCD VQYSPNLQND DPNITIENKE |
| | EKNINTDITI CDGSIIPNNK NYTYNNYRNE EKNRIRNNCQ GVINMIHDND NMNYHPISKK RFGYFKDKNF SYNKHVEADN |
| | NVRNYVDHTS INISTYNDSY KTNFQRKKDY NSYMTMPYSN KKDIKYYKKK GKIERRIKEH NCYSGIIGEN ERNKIIDNIG |
| | VTTSNGYITH NIQNIQNIQN IQNIQNFKNI PNVKNMQNVQ NIPNISKISN MPNISNISNG SNIPNMYNIT NIPQIVKGQD |
| | QFCNSTYGRS NKERKAIISS NSTTNLTFDT KKKATQNTWV IDHINNEEEE QMNNITSISN TTVNCYKSEF SCYKDNYKYK |
| | KHSTHISTPN YSMNKDNGVL NVISSVDKLV KNEYMYNEEK GRKRANKINN KMNWQKKGFM LEQNREKINI VLNEEMNMPN |
| | VVNCTNTPTV LNDAKESQTY DELKQKKKNK KKIEELCCMK KSIDMLHVRS RSENFHCRKN SFKNLEISMM KPHMQHFEQS |
| | INMEGFRCIL SKMMINYEGD MLVDDQEEEE KEEEKKGQEK GHKCECKCEC KCQCQCQCEQ YNDNKKHPEH DKEDNIIQKK |
| | DDDEIKTEKD HKEEEQEIYN TKEEPQYYSN NNVHNESYVT HHDSLKNNET ISTNTSGCSM IKNDDSFGDS VISNSYVYKE |
| | NDLNTNSCIN KLKQLKDDNI KKDNSMKETY MNNMNMNTMD SIHFDSIHID SLHIDNLHID NININTTNNI YKNGDITNNN |
| | RNGGDVNRAL FNSRENITDD YSMKTQNTFL CIYDENNKEM FDKKKKKKGF YQKNDLSMKK DVGGDIILNK HSLEEKNNCD |
| | LTIYTNNINN TDKNMENCYD TSCATKTYDN INSRKFGIDT YVKESAKITN RLWNNNIDRY SYKNGRNGVY YNEYGKMEGG |
| | TYDYHPSNMM YKKFGKNNDN DNDNNNDNNN DNNNNIDDDN NNENNNNNND DNNNINNDDN NNNNNDDNNN NNDKSNSMNN |
| | NFGNYHNNNS NSNSHYNNYH HNNNYHHNNN YHHHNNYHHH NNYHHHNNYH HNNYHGNNHF NNYHHNNMNS YNEGRTIPNN |
| | SYSGKNSYNN NMGEHINNID ITAGQRVLKD DMNKNNLYMV HNQHNFEEYK NYMNTNVIRY NNLHKKKYVT GTNYQVSNYN |
| | DTYHFNNMRG KQYYLNKYNY NNHHDMVYTN GKNVDVYKHM RANNKIETYN HMINGMNDIN VNNNVRNNTN SYSNDSYLHA |
| | QSGDVQKVYT NDEIVNDKHN NNDNNNDNDN ICNSSNNNMV AVDINEENNK NNKSNKSEVI NKCDDNNDEH DKMDSKSVVS |
| | YKSYGNKSGI SDKYFNKHNN ENNYKYSNNN YFNQSNDMNK ITNKYMNHNY SNDNFKDNYN NSNDKKKNLH YFKKNKMNNT |
| | FNSNRNKYGI ENYDDVNYPK DYNEDKMNNN NNNNKNRDRH NYHTGDRNNY YYHNHKNGYD FGVENIPSQI KRRHRKYMPA |
| | NNYQLNENHS TMNNNNNNNN NNNNNDNNNY NYDYNNNNKK YYYNNNYNNN DYYYYCNDDN YYKQTYEKNN QDYHNDEFNL |
| | PINYYEDNIK ENNQMKDNNE FFKTEEKINE ENKVEKEDSN EEREKIKNEK FMCDENLIRD EKLTCDEKLT CDEKLTCDEK |
| | LTCDEKLIRD EKLTCDEKLT CDEKLMHDEI EGDRKKIQEN VIPSKVDKDI KRRKKKEHFN NSFSKTNIFN NSYNIKNLNN |
| | For pricing and availability Click Here >>> |
| | cDNA-Asparagine-rich-antigen-Pfa35-2-Plasmodium-falciparum |
| | FOR in vitro RESEARCH USE ONLY. NOT FOR USE IN HUMANS. |
|
| ||||||||||||||||||||||||||||||||||
| |||||
| For cDNA or Recombinant Protein Search (Input Cat#, Gene name, Protein Name, Accession Number |
|
Copyright Bioclone Inc All rights Reserved